International Finance Corporation (IFC), the private sector arm of the World Bank Group, is extending a $40 million loan to the Mumbai-based pharmaceutical manufacturer Glenmark, according to an announcement.
The loan, which will be issued under IFC’s $8 billion, fast-track COVID-19 facility, seeks to help the Indian company boost its generic drug production capacity.